Metal Intervention Network and Therapy (MINT) Program: Studying and Targeting Metal Response in Tumor Radioresistance

MINT

Metal Intervention Network and Therapy Program: Studying and Targeting Metal Response in Tumor Radioresistance

About half of all of cancer patients, including those with thoracic (lung and chest) cancers, receive radiation therapy (RT) as part of their treatment. However, many patients don’t respond to RT due to radioresistance – either intrinsic resistance to RT or acquired resistance after initially responding to treatment, leading to recurrence of the cancer. This underscores the urgent need to understand why radioresistance occurs and to identify new treatments for it.

Metal ions are essential for many normal cell functions, but abnormal levels of some metals can cause oxidative stress and cell death. When metal levels in cells are not properly regulated, it can lead to therapy resistance, including RT.

This project aims to investigate the fundamental mechanisms of metal chemistry and biology in order to develop strategies to combat radioresistance in thoracic cancers. The multidisciplinary research team, led by experts in cancer biology, radiation oncology and chemical biology, will use advanced tools and resources from their institutions to bridge the gap between basic research in metal chemistry and the clinical applications of metal-based therapies to target radioresistance. The goal is to advance the understanding of metal chemistry and biology, paving the way for new metal-based therapies to overcome radioresistance in cancer treatment.

 

Team Members

MD Anderson

Boyi Gan, Professor
Experimental Radiation Oncology

Jared Burks, Professor
Leukemia

Albert Koong, Professor and Division Head
Radiation Oncology

Ziyi Li, Assistant Professor
Biostatistics

Steven H. Lin, Professor
Radiation Oncology

Charles Manning, Professor
Cancer Systems Imaging

Nicholas Navin, Professor and Chair
Systems Biology

UT Austin

Eun Jeong Cho, Research Scientist
College of Pharmacy

Yi Lu, Professor
Chemistry, College of Natural Sciences

Vagheesh Narasimhan, Assistant Professor
Integrative Biology, College of Natural Sciences

Erin H. Seeley
Mass Spectrometry Imaging Facility Director
Chemistry, College of Natural Sciences

 

News


Three people stand in front of a large screen displaying various scientific and mathematical visualizations. The screen shows multiple graphs, charts, and images with color-coded data, including heat maps and 3D models. The figures are silhouetted against the brightly lit display.

March 25, 2025

UT Austin and MD Anderson Launch Joint Initiative to Advance Breakthroughs in Cancer Research

The University of Texas at Austin and The University of Texas MD Anderson Cancer Center have launched a joint initiative, the Collaborative Accelerator for Transformative Research Endeavors, to enable groundbreaking research projects that align complementary strengths to improve cancer prevention, diagnosis, treatment and survival.